Virulence Traits Associated with ST856 Epidemic Strain Isolated from Cystic Fibrosis Patients

Overview

Journal Antimicrob Resist Infect Control

Publisher Biomed Central

Specialty Infectious Diseases

Date 2017 Jun 9

PMID 28593045

Citations 4

Authors

Milka Malesevic

Zorica Vasiljevic

Aleksandar Sovtic

Brankica Filipic

Katarina Novovic

Milan Kojic

Branko Jovcic

Affiliations

Soon will be listed here.

Abstract

Background: is considered one of the most problematic cystic fibrosis (CF) pathogens. Colonization prevalence in the Serbian CF population is high and virtually exclusively limited to a single highly transmissible clone of ST856 which is positive for both the epidemic strain marker (BCESM) and cable pilin, and is closely related to the epidemic strain CZ1 (ST32).

Methods: Biofilm formation for 182 isolates, and adhesion to components of the host extracellular matrix, proteolytic activity, mucoidy and motility of selected ST856 representatives, as well as ST858 and ST859, and ST857, novel STs isolated from Serbian CF patients, were investigated in this study. The presence of the , , , , , and genes was analyzed.

Results: Biofilm-formation ability of analyzed strains was poor under standard laboratory conditions, but changed in stress conditions (cold stress) and conditions that mimic CF milieu (increased CO). All strains expressed ability to bind to collagen and fibronectin albeit with different intensity. Representatives of ST856 exhibited gelatinase activity. ST858, ST859 and 9/11 of ST856 genotypes were positive for swimming and twitching motility whereas ST857 was non-motile. Mucoidy was demonstrated in all ST856 genotypes, ST857 was semi-mucoid, and ST858 and ST859 were non-mucoid. Molecular analysis for major virulence factors revealed that ST856 and ST857 carried the six analyzed genes, while ST858 and ST859 were negative for the gene.

Conclusion: Variations in virulence phenotypes in different genotypes of epidemic ST856 clone, in vitro, could be a consequence of diversification driven by pathoadaptation. Diversity of epidemic clone genotypes virulence, could be challenging for accurate diagnosis and treatment, as well as for infection control.

Citing Articles

Epidemiology, microbiological, clinical characteristics, and outcome of complex infections in non-cystic fibrosis adult patients from Qatar.

Ibrahim T, Abdallah T, Abdallah A, Qazi R, Alimam A, Mohammad H IJID Reg. 2024; 11:100355.

PMID: 38617502 PMC: 11015122. DOI: 10.1016/j.ijregi.2024.03.010.

Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future.

Perikleous E, Gkentzi D, Bertzouanis A, Paraskakis E, Sovtic A, Fouzas S Antibiotics (Basel). 2023; 12(2).

PMID: 36830128 PMC: 9951886. DOI: 10.3390/antibiotics12020217.

Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.

Jaiyesimi O, McAvoy A, Fogg D, Garg N Sci Rep. 2021; 11(1):21419.

PMID: 34725378 PMC: 8560942. DOI: 10.1038/s41598-021-00421-4.

Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Scoffone V, Chiarelli L, Trespidi G, Mentasti M, Riccardi G, Buroni S Front Microbiol. 2017; 8:1592.

PMID: 28878751 PMC: 5572248. DOI: 10.3389/fmicb.2017.01592.

References

Speert D, Henry D, Vandamme P, Corey M, Mahenthiralingam E . Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis. 2002; 8(2):181-7. PMC: 3369581. DOI: 10.3201/eid0802.010163. View

Graindorge A, Menard A, Neto M, Bouvet C, Miollan R, Gaillard S . Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis. 2009; 66(1):29-40. DOI: 10.1016/j.diagmicrobio.2009.06.008. View

Nair B, Joachimiak L, Chattopadhyay S, Montano I, Burns J . Conservation of a novel protein associated with an antibiotic efflux operon in Burkholderia cenocepacia. FEMS Microbiol Lett. 2005; 245(2):337-44. DOI: 10.1016/j.femsle.2005.03.027. View

Cullen L, McClean S . Bacterial Adaptation during Chronic Respiratory Infections. Pathogens. 2015; 4(1):66-89. PMC: 4384073. DOI: 10.3390/pathogens4010066. View

Gingues S, Kooi C, Visser M, Subsin B, Sokol P . Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol. 2005; 187(24):8247-55. PMC: 1316997. DOI: 10.1128/JB.187.24.8247-8255.2005. View

Pezzulo A, Tang X, Hoegger M, Abou Alaiwa M, Ramachandran S, Moninger T . Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012; 487(7405):109-13. PMC: 3390761. DOI: 10.1038/nature11130. View

Tomich M, Griffith A, Herfst C, Burns J, Mohr C . Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun. 2003; 71(3):1405-15. PMC: 148827. DOI: 10.1128/IAI.71.3.1405-1415.2003. View

Zlosnik J, Hird T, Fraenkel M, Moreira L, Henry D, Speert D . Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol. 2008; 46(4):1470-3. PMC: 2292898. DOI: 10.1128/JCM.02273-07. View

Schwab U, Abdullah L, Perlmutt O, Albert D, Davis C, Arnold R . Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun. 2014; 82(11):4729-45. PMC: 4249344. DOI: 10.1128/IAI.01876-14. View

10.

Silva I, Ferreira A, Becker J, Zlosnik J, Speert D, He J . Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology (Reading). 2011; 157(Pt 11):3124-3137. DOI: 10.1099/mic.0.050989-0. View

11.

Tate S, MacGregor G, Davis M, Innes J, Greening A . Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax. 2002; 57(11):926-9. PMC: 1746233. DOI: 10.1136/thorax.57.11.926. View

12.

Jakobsen T, Hansen M, Jensen P, Hansen L, Riber L, Cockburn A . Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One. 2013; 8(7):e68484. PMC: 3718787. DOI: 10.1371/journal.pone.0068484. View

13.

Schwab U, Leigh M, Ribeiro C, Yankaskas J, Burns K, Gilligan P . Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun. 2002; 70(8):4547-55. PMC: 128168. DOI: 10.1128/IAI.70.8.4547-4555.2002. View

14.

Goldberg J, Ganesan S, Comstock A, Zhao Y, Sajjan U . Cable pili and the associated 22 kDa adhesin contribute to Burkholderia cenocepacia persistence in vivo. PLoS One. 2011; 6(7):e22435. PMC: 3141045. DOI: 10.1371/journal.pone.0022435. View

15.

Drevinek P, Mahenthiralingam E . Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect. 2010; 16(7):821-30. DOI: 10.1111/j.1469-0691.2010.03237.x. View

16.

Trancassini M, Iebba V, Citera N, Tuccio V, Magni A, Varesi P . Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front Microbiol. 2014; 5:138. PMC: 3982067. DOI: 10.3389/fmicb.2014.00138. View

17.

Podnecky N, Rhodes K, Schweizer H . Eﬄux pump-mediated drug resistance in Burkholderia. Front Microbiol. 2015; 6:305. PMC: 4396416. DOI: 10.3389/fmicb.2015.00305. View

18.

Miljkovic M, Strahinic I, Tolinacki M, Zivkovic M, Kojic S, Golic N . AggLb Is the Largest Cell-Aggregation Factor from Lactobacillus paracasei Subsp. paracasei BGNJ1-64, Functions in Collagen Adhesion, and Pathogen Exclusion In Vitro. PLoS One. 2015; 10(5):e0126387. PMC: 4425601. DOI: 10.1371/journal.pone.0126387. View

19.

Dennis J . Burkholderia cenocepacia virulence microevolution in the CF lung: Variations on a theme. Virulence. 2016; 8(6):618-620. PMC: 5626197. DOI: 10.1080/21505594.2016.1253660. View

20.

Govan J, Brown A, Jones A . Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2007; 2(2):153-64. DOI: 10.2217/17460913.2.2.153. View